FdaApplication
ANDA 202012
Identifiers
- fda_app_no: ANDA202012
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2011-11-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPROSARTAN MESYLATE | EPROSARTAN MESYLATE | EQ 400MG BASE | TABLET;ORAL |
| EPROSARTAN MESYLATE | EPROSARTAN MESYLATE | EQ 600MG BASE | TABLET;ORAL |
2 products